GPR92/LPA5 lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques

Cardiovascular Research

Volumn 90, Issue 1, 2011, Pages 157-164

  Khandoga, Anna L ^a   Pandey, Dharmendra ^a   Welsch, Ulrich ^a   Brandl, Richard ^b   Siess, Wolfgang ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Clinic Schwabing   (Germany)

Author keywords

Atherosclerosis; Plaque rupture; Platelets; Receptors; Thrombosis

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MESSENGER RNA; RHO KINASE; SMALL INTERFERING RNA; LPAR5 PROTEIN, HUMAN; LYSOPHOSPHOLIPID;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL SHAPE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; THROMBOCYTE; ATHEROSCLEROSIS; CELL LINE; GENETIC TRANSFECTION; GENETICS; LIPID METABOLISM; METABOLISM; PATHOLOGY; PHOTOMETRY; RNA INTERFERENCE; SCANNING ELECTRON MICROSCOPY; TIME;

ATHEROSCLEROSIS; CELL LINE; CELL SHAPE; HUMANS; LIPID METABOLISM; LYSOPHOSPHOLIPIDS; MEGAKARYOCYTES; MICROSCOPY, ELECTRON, SCANNING; NEPHELOMETRY AND TURBIDIMETRY; RECEPTORS, LYSOPHOSPHATIDIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION;

EID: 79952842711     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq369     Document Type: Article

References (30)

1. SiessW, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 1999;96:6931-6936. (Pubitemid 29274987)
2. Siess W, Tigyi G. Thrombogenic and atherogenic activities of lysophosphatidic acid. J Cell Biochem 2004;92:1086-1094. (Pubitemid 44264220)
3. Bot M, Bot I, Lopez-Vales R, van de Lest CH, Saulnier-Blache JS, Helms JB et al. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol 2010;176:3073-3084.
4. Schumacher KA, Classen HG, Spath M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: identity with substances in aged serum (DAS). Thromb Haemost 1979;42:631-640. (Pubitemid 10229876)
5. Haseruck N, Erl W, Pandey D, Tigyi G, Ohlmann P, Ravanat C et al. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 2004; 103:2585-2592. (Pubitemid 38393011)
6. Tokumura A, Fukuzawa K, Isobe J, Tsukatani H. Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship. Biochem Biophys Res Commun 1981;99:391-398. (Pubitemid 12195962)
7. Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G et al. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 2003;108:741-747. (Pubitemid 36999261)
8. Bauer M, Retzer M, Wilde JI, Maschberger P, Essler M, Aepfelbacher M et al. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets. Blood 1999;94:1665-1672. (Pubitemid 29411316)
9. Pandey D, Goyal P, Siess W. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation. Blood Cells Mol Dis 2007;38:269-279. (Pubitemid 46518177)
10. Retzer M, Essler M. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation. Cell Signal 2000;12:645-648.
11. Pandey D, Goyal P, Bamburg JR, Siess W. Regulation of LIM-kinase 1 and cofilin in thrombin-stimulated platelets. Blood 2006;107:575-583. (Pubitemid 43076381)
12. Maschberger P, Bauer M, Baumann-Siemons J, Zangl KJ, Negrescu EV, Reininger AJ et al. Mildly oxidized low density lipoprotein rapidly stimulates via activation of the lysophosphatidic acid receptor Src family and Syk tyrosine kinases and Ca2+ influx in human platelets. J Biol Chem 2000;275:19159-19166. (Pubitemid 30422886)
13. Noguchi K, Ishii S, Shimizu T. Identification of p2y9/GPR23 as a novel G proteincoupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003;278:25600-25606. (Pubitemid 36835313)
14. Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. GPR92 as a new G12/13-and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 2006;281:23589-23597. (Pubitemid 44274133)
15. Tabata K, Baba K, Shiraishi A, Ito M, Fujita N. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 2007;363:861-866. (Pubitemid 47516713)
16. Murakami M, Shiraishi A, Tabata K, Fujita N. Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. Biochem Biophys Res Commun 2008;371:707-712.
17. Yanagida K, Masago K, Nakanishi H, Kihara Y, Hamano F, Tajima Y et al. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J Biol Chem 2009;284:17731-17741.
18. Yin H, Chu A, LiW,Wang B, Shelton F, Otero F et al. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 2009;284: 12328-12338.
19. Ishii S, Noguchi K, Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 2009;89:57-65.
20. Khandoga AL, Fujiwara Y, Goyal P, Pandey D, Tsukahara R, Bolen A et al. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptorselective probes and albumin. Platelets 2008;19:415-427.
21. Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, Siess W et al. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem 2009;284:17304-17319.
22. Leon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997;403:26-30. (Pubitemid 27079803)
23. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I et al. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 2005;19:898-909. (Pubitemid 40827712)
24. Brandl R, Richter T, Haug K, Wilhelm MG, Maurer PC, Nathrath W. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation 1997;96: 3360-3368. (Pubitemid 27513406)
25. Yazaki A, Tamaru S, Sasaki Y, Komatsu N, Wada H, Shiku H et al. Inhibition by Rhokinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO. Cell Signal 2005;17: 321-330. (Pubitemid 39574693)
26. Negrescu EV, de Quintana KL, Siess W. Platelet shape change induced by thrombin receptor activation. Rapid stimulation of tyrosine phosphorylation of novel protein substrates through an integrin-and Ca(2+)-independent mechanism. J Biol Chem 1995;270:1057-1061.
27. Withey JM, Marley SB, Kaeda J, Harvey AJ, Crompton MR, Gordon MY. Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells. Br J Haematol 2005;129:377-380. (Pubitemid 40646897)
28. Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, Schneider S et al. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 2008;103:356-367.
29. van der Vuurst H, van Willigen G, van Spronsen A, Hendriks M, Donath J, Akkerman JW. Signal transduction through trimeric G proteins in megakaryoblastic cell lines. Arterioscler Thromb Vasc Biol 1997;17:1830-1836. (Pubitemid 27424008)
30. van der Vuurst H, Hendriks M, Lapetina EG, van Willigen G, Akkerman JW. Maturation of megakaryoblastic cells is accompanied by upregulation of G(s)alpha-L subtype and increased cAMP accumulation. Thromb Haemost 1998; 79:1014-1020. (Pubitemid 28224742)